Artificial intelligence has taken many forms over the years and is still evolving. Will machines soon surpass human knowledge and understanding?

Throughline is a time machine. Each episode, we travel beyond the headlines to answer the question, "How did we get here?" We use sound and stories to bring history to life and put you into the middle ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...